Faster measurement of response to antibiotic treatment in sepsis patients using Dimeric HNL
The biomarker human neutrophil lipocalin HNL, which was previously shown to be a useful indicator of bacterial infections, may also in the form of Dimeric HNL be used to effectively monitor the success of antibiotic treatment in sepsis. The first promising results in this regard were published in 2019 and now the research group has confirmed these results in a larger study. The study is published in the journal PLOS ONE.
Sepsis, the costliest disease to health care, is a life-threatening condition with high mortality if not diagnosed and ...














